Abbott published findings from the AVEIR DR i2i study evaluating the company's novel dual-chamber leadless pacemaker (LP) ...

AVON LAKE, Ohio — A 61-year-old Avon Lake man clinically died multiple times and lived to tell about it. His incredible ...

CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Gearing Up for Phase 3 Trial of Tecarfarin Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) is a biopharmaceutical company developing tecarfarin, a ...

4D model-guided cardiac resynchronization lead placement improved left ventricular function vs ... The audience will look forward to the potential long-term comparative outcomes from the study.” ...

Of the dozens of looks at the Met Gala, these 15 stood out as some that will be hard to forget, just like the blue carpet, which had a daffodil print that gave it more pizazz than the average red rug.

A left ventricular assist device (LVAD ... different than what is expected in any other patient out there. Let’s look at what we need to know with a patient who has a VAD who is having a ...

“I just knew something was wrong.” Dr. Jerome Thomas and Micah Wesley sit down with KXAN to talk about LVAD. (Photo by Frank Martinez) Doctors told her the only option left was a Left ...

For ventricular tachycardia (VT), catheter ablation ... VT is their motivation for seeking treatment. “Some people may look for an intervention that helps them live longer vs helping them ...

US-based Supira Medical has completed a $120m Series E funding round, with plans to use the capital to advance its position in the percutaneous ventricular assist device ... team’s tremendous progress ...

One of the factors is body image, which is associated with the prospect of spending the rest of life with the LVAD and associated limitations (e.g., first look in the mirror) (43). Rapelli G. et al., ...

Its effect on ventricular tachycardia can readily be shown ... where the reviewer had the opportunity to look continuously at the histogram of the last 160 or, if he wished, the last 200, 500 ...